CYP1A1 and breast carcinoma: The studies conducted by Lee and Safe [83] confirmed the inhibition of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) induced CYP1A1 activity and expression by resveratrol at a dose of 10 μM in MCF7 and T47D breast cancer cell lines.